Foghorn Therapeutics Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Mar 6 '25±51.7%▲+0.44%×0.01

May 14 '25±28.7%▼−5.08%×0.18

Aug 5 '25±26.8%▼−2.72%×0.10

Q3 FY25±85.0%▲+13.31%×0.16

Jan 12 '26±84.2%▲+23.64%×0.28

Q1 FY26±13.9%▼−12.92%×0.93

May 7 '26±62.5%▼−10.26%×0.16

Q2 FY26±84.1%▲+14.14%×0.17

quarterimplied−85%0+85%realized×

Q2 FY26±84.1%▲+14.14%×0.17

May '26±62.5%▼−10.26%×0.16

Q1 FY26±13.9%▼−12.92%×0.93

Jan '26±84.2%▲+23.64%×0.28

Q3 FY25±85.0%▲+13.31%×0.16

Aug '25±26.8%▼−2.72%×0.10

2 older reports

May '25±28.7%▼−5.08%×0.18

Mar '25±51.7%▲+0.44%×0.01

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull2

3tracked funds holding FHTXN-PORT · Aug 31 '26

102managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history

0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

FHTX report session

No linked exposure.

Oct 22impliedImplied move: ±35.6% into Nov 4 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.